7881 - 7890 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Structure–Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor AgonistsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 12Start Page: 1818End Page: 1831Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00235Citation Count: 3
- LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domains2022OPENTitle: LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domainsJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 20Issue #: 2Start Page: e3001427End Page: e3001427Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3001427Best OA location URL: https://doi.org/10.1371/journal.pbio.3001427Citation Count: 25
-
OPENTitle: GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 22Issue #: 17Start Page: 5625End Page: 5629Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.06.104Best OA location URL: http://hdl.handle.net/10871/35665Citation Count: 149
- Smell status in functional movement disorders: New clues for diagnosis and underlying mechanisms2019RESTRICTEDTitle: Smell status in functional movement disorders: New clues for diagnosis and underlying mechanismsJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 177Issue #:Start Page: 68End Page: 72Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2018.12.017Best OA location URL: https://repositorio.udes.edu.co/handle/001/3108Citation Count: 4
-
OPENTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7939141Citation Count: 18
-
RESTRICTEDTitle: Microlesion effects, suboptimal lead placement and disease progression are critical determinants for DBS tolerance in essential tremorJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 129Issue #: 10Start Page: 2215End Page: 2216Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2018.07.024Citation Count: 4
-
RESTRICTEDTitle: Detection of Proteolytic Signatures for Parkinson's DiseaseJournal Name: Future NeurologyPublisher: Informa UK LimitedVol: 11Issue #: 1Start Page: 15End Page: 32Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/fnl.16.3Citation Count: 0
-
RESTRICTEDTitle: Genetic characterization of a cohort with familial parkinsonism and cognitive-behavioral syndrome: A Next Generation Sequencing studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 82End Page: 90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.024Citation Count: 2
-
OPENTitle: Sex, Age, and Emotional Valence: Revealing Possible Biases in the ‘Reading the Mind in the Eyes’ TaskJournal Name: Frontiers in PsychologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyg.2018.00570Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyg.2018.00570/pdfCitation Count: 18
-
OPENTitle: Longitudinal Trajectories of Memory Performance in Patients with Early-Stage Breast CancerJournal Name: Journal of OncologyPublisher: WileyVol: 2022Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/5899728Best OA location URL: https://downloads.hindawi.com/journals/jo/2022/5899728.pdfCitation Count: 1